ERα-IN-3
ERα-IN-3 is a ERα inhibitor with an IC50 of 74.48 μM. ERα-IN-3 induces cell cycle arrest at the G0/G1 and G2/M checkpoints and triggers Apoptosis. ERα-IN-3 exhibits anticancer effects against ER-positive breast cancer. ERα-IN-3 can be used for the research of ERα-positive breast cancer.
For research use only. We do not sell to patients.
- Formula: C25H21N3O4
- Molecular Weight:427.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
ERα 74.48 μM (IC50) |
In Vitro
ERα-IN-3 inhibits ERα with an IC50 value of 74.48 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T-47D
-
Concentration:25 μM
-
Incubation Time:48 h
-
Result:Induced cell cycle arrest with 59.7% of cells in the G0/G1 phase, 9.8% in the S phase, and 26.3% in the G2/M phase.
-
Cell Line:T-47D
-
Concentration:25 μM
-
Incubation Time:48 h
-
Result:Induced total apoptosis in approximately 40% of T-47D cells.
Showed early and late apoptotic populations lower than those induced by compound 21 and bazedoxifene but higher than those induced by tamoxifen.
Chemical Information
-
Molecular Weight 427.45
-
Formula C25H21N3O4
-
SMILES
O=[N+](C1=CC(C2=NOC(C3=CN(CC4=CC=CC(OC)=C4)C5=C3C=CC=C5)C2)=CC=C1)[O-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)